Cronos Group is a publicly traded Canadian company that produces and sells cannabis products. The company has operations in Canada, Germany, Israel, and Australia. Cronos Group's customer support number is 1-844-276-6797. The company's headquarters is located in Toronto, Canada.
What is Cronos (CRO)?
Cronos is a digital asset and payment platform that enables users to securely buy, sell, and store digital assets. It offers a range of features including a wallet, a marketplace, and an exchange. Cronos also allows users to earn rewards in the form of CRON tokens for participating in its ecosystem.
Cronos (CRO) support
Cronos is a digital currency that uses blockchain technology. It is based on the Ethereum platform. Cronos has a total supply of 100 million coins.
Cronos (CRO) phone number
Cronos is a Canadian telecommunications company, founded in 1996 by Mike Lazaridis and David Gold. It offers services in Canada, the United States, and Mexico.
The company was founded in 1996 by Mike Lazaridis and David Gold. It offers services in Canada, the United States, and Mexico.
As of 2018, Cronos had over 1.5 million subscribers.
In June 2019, it was announced that Cronos had entered into an agreement to sell its US cannabis operations to Constellation Brands for US$3.8 billion.
Cronos (CRO) customer care
Cronos customer care is available 24/7 to assist with any questions or issues you may have. You can reach them by phone, email, or live chat.
Cronos (CRO) headquarters
Cronos is a Canadian-based cannabis company with production facilities in Canada, Denmark, and Israel. It is one of the first publicly traded companies to list its shares on the Canadian Securities Exchange.
The company has two primary products: dried cannabis and cannabis oil. Cronos plans to produce over 1 million kilograms of dried cannabis per year and over 500,000 kilograms of cannabis oil.
Cronos was founded in 2004 by Mike Gorenstein and Ian Cusson. In 2006, the company acquired a license to cultivate medical marijuana in Canada. Cronos became one of the first licensed producers of medical marijuana in Canada.
In January 2018, Cronos announced that it had signed a binding agreement to acquire MedReleaf, a Canadian cannabis company with a production facility in Ontario. The acquisition was completed in February 2018.
Cronos is one of the first publicly traded companies to list its shares on the Canadian Securities Exchange. The company's stock price has increased by more than 400% since its initial public offering in February 2018.